Incomplete Care Plans and Missing Monitoring for CVA Prophylaxis, Anxiety, and Blood Glucose
Summary
Resident 32 had an admission record showing diagnoses including heart failure, morbid obesity, and difficulty walking. Hospital discharge records indicated the resident was to continue enoxaparin 0.4 ml once daily subcutaneously, and the physician order summary showed enoxaparin 40 mg/0.4 ml SQ in the evening for CVA prophylaxis starting 5/19/2026. The resident’s care plan, initiated 5/4/2026, was not revised and did not include goals, duration, or outcomes for enoxaparin use for CVA prophylaxis. During a concurrent record review and interview, the DON reviewed the admission record, order summary, and care plan and acknowledged that the care plan did not have goals, duration, or outcomes for enoxaparin use for CVA prophylaxis. The DON stated the care plan should include goals, duration, and outcomes for residents’ areas of concern and that the lack of a care plan for enoxaparin did not provide person-centered care for Resident 32. The DON also stated that without a care plan for enoxaparin, the facility would not be able to identify improvements or concerns or determine whether goals were met with the current treatment for CVA prophylaxis. Resident 75 had an admission record showing a diagnosis including anxiety. The physician order summary indicated buspirone 10 mg, one tablet by mouth twice daily for anxiety manifested by repetitive worrying about her health condition. The care plan, revised 9/18/2024, included an intervention to monitor episodes of anxiety manifested by repetitive worrying about her health condition every shift, but the May and June 2026 MARs did not contain documentation that this monitoring occurred every shift. The DON acknowledged the care plan required every-shift monitoring for anxiety related to buspirone use and that the MARs did not show the monitoring was completed. Resident 48 had diagnoses including acute respiratory failure, type II diabetes mellitus, and sepsis, and the MDS indicated severely impaired cognition. The physician order summary included heparin for DVT prophylaxis and insulin lispro sliding scale with instructions to notify the physician if blood glucose was less than 70 mg/dL or greater than 400 mg/dL. The care plan identified the resident as at risk for hypoglycemia and hyperglycemia and included monitoring for signs and symptoms of both conditions, but the EMAR from 5/17/2026 to 5/31/2026 did not show documentation that the resident was monitored for hypoglycemia or hyperglycemia. The DON reviewed the EMAR and stated there was no record indicating the resident was monitored for these conditions.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.